SCHEMBL9564302

SCHEMBL9564302

O=C(O)c1ccc2c(c1)C(=O)N(c1ccc(Oc3ccc(N4C(=O)c5ccc(C(=O)O)cc5C4=O)cc3)cc1)C2=O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.68
CA9 Q16790 8/20 0.66
CA1 P00915 7/20 0.66
CA2 P00918 4/20 0.66
CA4 P22748 2/20 0.66
LPAR1 Q92633 1/20 0.65
LPAR5 Q9H1C0 1/20 0.65
LPAR3 Q9UBY5 1/20 0.65
MEN1 O00255 3/20 0.64
KMT2A Q03164 3/20 0.64
GFER P55789 1/20 0.64
NPSR1 Q6W5P4 2/20 0.63
MAPK1 P28482 1/20 0.63
CA12 O43570 6/20 0.62
HSD17B10 Q99714 1/20 0.60
SCN2A Q99250 1/20 0.59
PTGES O14684 1/20 0.58
ALDH1A1 P00352 2/20 0.57
MAPT P10636 1/20 0.57
RAB9A P51151 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20513018 0.93 POLB (0.65) POLBCA9CA1CA2CA4
SCHEMBL9803534 0.92 LPAR1 (0.77) POLBCA9CA1CA2CA4
SCHEMBL12311922 0.91 ALDH1A1 (0.63) POLBCA9CA1CA2CA4
SCHEMBL9339007 0.91 CA9 (0.77) POLBCA9CA1CA2CA4
SCHEMBL25161442 0.90 CA9 (0.65) POLBCA9CA1CA2CA4
SCHEMBL16146993 0.90 NPSR1 (0.74) POLBCA9CA1CA2CA4
SCHEMBL4234750 0.89 CA9 (0.77) POLBCA9CA1CA2CA4
SCHEMBL5010660 0.88 ALDH1A1 (0.70) POLBCA9CA1CA2CA4
SCHEMBL17281694 0.87 PTGES (0.64) POLBCA9CA1CA2CA4
SCHEMBL11947936 0.87 POLB (0.75) POLBCA9CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753502-B2 Oligomer, composition, packaging structure, and method of disassembling packaging structure INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2023-09-12 US disclosed
US-20230117528-A1 OLIGOMER, COMPOSITION, PACKAGING STRUCTURE, AND METHOD OF DISASSEMBLING PACKAGING STRUCTURE INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2023-04-20 US disclosed
US-20180086704-A1 METHOD FOR PRODUCING BISIMIDE DICARBOXYLIC ACID UNITIKA LTD. (JP) 2018-03-29 US disclosed
US-20180086704-A1 METHOD FOR PRODUCING BISIMIDE DICARBOXYLIC ACID UNITIKA LTD. (JP) 2018-03-29 US disclosed
EP-0554741-A1 Amidoimidobisphenoles, their preparation and thermostables polymers derived thereof DSM Chemie Linz GmbH (AT) 1993-08-11 EP disclosed
EP-0258767-B1 WHOLLY AROMATIC THERMOTROPIC POLYESTERS BASF Aktiengesellschaft (DE) 1992-06-24 EP disclosed
US-5092890-A Thermotropic mesomorphic polymer, apatite, filler BASF AKTIENGESELLSCHAFT (DE) 1992-03-03 US disclosed
EP-0225537-B1 WHOLLY AROMATIC MESOGENIC POLYESTERIMIDES, THEIR FABRICATION AND USE BASF Aktiengesellschaft (DE) 1991-03-27 EP disclosed
US-RE33315-E Wholly aromatic mesomorphic polyester amide imides and the preparation thereof BASF AKTIENGESELLSCHAFT (DE) 1990-08-28 US disclosed
EP-0378102-A2 Implantation materials BASF Aktiengesellschaft (DE) 1990-07-18 EP disclosed
US-4728714-A Wholly aromatic mesomorphic polyester imides, the preparation and use thereof BASF AKTIENGESELLSCHAFT (DE) 1988-03-01 US disclosed
US-4727129-A Wholly aromatic mesomorphic polyester amide imides and the preparation thereof BASF AKTIENGESELLSCHAFT (DE) 1988-02-23 US disclosed
EP-0231468-A2 Liquid crystal polycondensates containing carbamide groups, their preparation and their use BASF Aktiengesellschaft (DE) 1987-08-12 EP disclosed
EP-0231462-A1 Wholly aromatic mesomorphous polyether ester imides, their preparation and use BASF Aktiengesellschaft (DE) 1987-08-12 EP disclosed
EP-0230547-A2 Wholly aromatic mesomorphous polyester amide imides, their preparation and their use BASF Aktiengesellschaft (DE) 1987-08-05 EP disclosed
EP-0225537-A2 Wholly aromatic mesogenic polyesterimides, their fabrication and use BASF Aktiengesellschaft (DE) 1987-06-16 EP disclosed
EP-0074551-B1 MOULDING MASS CONTAINING TRIKETOIMIDAZOLIDINE PRECONDENSATES, THEIR USE AND PROCESS FOR THE PREPARATION OF A TRIKETOIMIDAZOLIDINE PRECONDENSATE COMPOSITE SUITED FOR IT HOECHST AKTIENGESELLSCHAFT (DE) 1986-07-16 EP disclosed
US-4497915-A Molding compositions containing triketoimidazolidine precondensates, their use, and a process for preparing a triketoimidazolidine precondensate composite suitable for this purpose HOECHST AKTIENGESELLSCHAFT (DE) 1985-02-05 US disclosed
US-4483947-A Molding compositions containing triketoimidazolidine precondensates, their use, and a process for preparing a triketoimidazolidine precondensate composite suitable for this purpose HOECHST AKTIENGESELLSCHAFT (DE) 1984-11-20 US disclosed
EP-0074551-A2 Moulding mass containing triketoimidazolidine precondensates, their use and process for the preparation of a triketoimidazolidine precondensate composite suited for it HOECHST AKTIENGESELLSCHAFT (DE) 1983-03-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086704-A1 METHOD FOR PRODUCING BISIMIDE DICARBOXYLIC ACID MCCC2, CA9, FHIT POLB 1393/4885CA9 2/4885CA1 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.